Alejandro Forner
Impact in
- Hepatology top 0.01%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 86
- Hepatocellular Carcinoma Treatment and Prognosis 83
- Liver Disease and Transplantation 13
- Liver physiology and pathology 6
- Epidemiology 50
- Liver Disease Diagnosis and Treatment 42
- Hepatitis B Virus Studies 13
- Co-authors
- Jordi Bruix (75 shared papers)Josep M. Llovet (16 shared papers)María Reig (61 shared papers)Jean‐Luc Raoul (6 shared papers)Vincenzo Mazzaferro (3 shared papers)Peter R. Galle (2 shared papers)Fabio Piscaglia (2 shared papers)Peter Schirmacher (1 shared paper)
- Journals
- Journal of Hepatology (25 papers)Hepatology (10 papers)Liver International (6 papers)Cancers (6 papers)European Radiology (4 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Alejandro Forner
115 papers receiving 25.8k citations
Alejandro Forner's Hit Papers
Peers
Comparison fields: 5 of 149
- Hepatology 15.8k
- Cancer Research 3.4k
- Epidemiology 5.9k
- Oncology 2.9k
- Pathology and Forensic Medicine 1.5k
Countries citing papers authored by Alejandro Forner
This map shows the geographic impact of Alejandro Forner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Forner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Forner more than expected).
Fields of papers citing papers by Alejandro Forner
This network shows the impact of papers produced by Alejandro Forner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Forner. The network helps show where Alejandro Forner may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Forner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma Hit paper breakdown → | 2018 | 7087 |
| 2 | Hepatocellular carcinoma Hit paper breakdown → | 2018 | 4228 |
| 3 | Hepatocellular carcinoma Hit paper breakdown → | 2012 | 3520 |
| 4 | BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update Hit paper breakdown → | 2021 | 2546 |
| 5 | Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects Hit paper breakdown → | 2010 | 903 |
| 6 | Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hit paper breakdown → | 2007 | 781 |
| 7 | Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics Hit paper breakdown → | 2006 | 734 |
| 8 | Management of HCC Hit paper breakdown → | 2012 | 520 |
| 9 | Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence Hit paper breakdown → | 2018 | 453 |
| 10 | Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization Hit paper breakdown → | 2010 | 435 |
| 11 | Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design Hit paper breakdown → | 2012 | 384 |
| 12 | Treatment of intermediate-stage hepatocellular carcinoma Hit paper breakdown → | 2014 | 370 |
| 13 | 2008 | 352 | |
| 14 | 2020 | 239 | |
| 15 | 2010 | 233 | |
| 16 | 2009 | 227 | |
| 17 | 2010 | 211 | |
| 18 | 2019 | 196 | |
| 19 | 2014 | 185 | |
| 20 | 2010 | 181 |
About Alejandro Forner
Alejandro Forner is a scholar working on Hepatology, Epidemiology, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 125 papers that have together received 26.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (83 papers), Liver Disease Diagnosis and Treatment (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Hepatitis B Virus Studies (13 papers), Liver Disease and Transplantation (13 papers), Pancreatic and Hepatic Oncology Research (10 papers), Liver physiology and pathology (6 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Hepatology (15.8k citations), Cancer Research (3.4k citations), Epidemiology (5.9k citations), Oncology (2.9k citations) and Pathology and Forensic Medicine (1.5k citations). Alejandro Forner has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Jordi Bruix, Josep M. Llovet, María Reig, Jean‐Luc Raoul, Vincenzo Mazzaferro, Peter R. Galle, Fabio Piscaglia, Peter Schirmacher, Valérie Vilgrain and Carmen Ayuso. Their work appears in journals such as Journal of Hepatology, Hepatology, Liver International, Cancers and European Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.